{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T16:40:50Z","timestamp":1786466450579,"version":"build-2736575974"},"reference-count":119,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000},"content-version":"am","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The role of myocardial revascularization in heart failure (HF) patients with coronary artery disease by either percutaneous coronary intervention (PCI) or coronary artery bypass graft surgery (CABG) is controversial. For patients with HFrEF, prior to the advances in pharmacological heart failure therapy over the last 10 years, evidence suggests a modest, long-term benefit of CABG over guideline-recommended medical therapy. In the era of modern medical therapy, revascularization had no benefit in HFrEF. Whether a patient with HF and CAD should be advised to have revascularization and, if so, which procedure remains unclear and should be discussed by the heart team given the limited and conflicting evidence. Evidence for viability or ischaemia-guided selection strategies is controversial. In all cases with HF, establishing and optimizing guideline-directed medical therapy (GDMT) and device therapy is required. When HF symptoms dominate despite GDMT, additional invasive procedures are not indicated. When angina persists despite GDMT and device therapy, revascularization should be considered. The choice of revascularization procedure should be discussed in the heart team, considering symptoms and ischaemic burden, surgical risk, coronary complexity, and the applicable HF treatment.<\/jats:p>","DOI":"10.1093\/ejhf\/xuag230","type":"journal-article","created":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T11:52:44Z","timestamp":1784807564000},"source":"Crossref","is-referenced-by-count":0,"title":["Revascularization of coronary artery disease in heart failure: a European Journal of Heart Failure expert consensus statement"],"prefix":"10.1093","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6109-431X","authenticated-orcid":false,"given":"Bernhard","family":"Haring","sequence":"first","affiliation":[{"name":"Department of Medicine IV and Karl Landsteiner Institute for Cardiovascular Research, Clinic Hietzing , Medical University of Vienna, Wolkersbergenstra\u00dfe 1, 1130 Vienna ,","place":["Austria"]},{"name":"Homburg Institute of CardioRenalMetabolic Medicine (HOMICAREM), Saarland University Klinik f\u00fcr Innere Medizin III and , Kirrberger Stra\u00dfe 100, 66421 Homburg\/Saar ,","place":["Germany"]},{"name":"Department of Epidemiology & Population Health, Albert Einstein College of Medicine , 1300 Morris Park Avenue, Bronx, NY 10461 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Iaconelli","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Fondazione Policlinico Universitario A. Gemelli IRCCS , Rome ,","place":["Italy"]},{"name":"School of Cardiovascular and Metabolic Health, University of Glasgow , Glasgow ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6362-1291","authenticated-orcid":false,"given":"Divaka","family":"Perera","sequence":"additional","affiliation":[{"name":"School of Cardiovascular and Metabolic Medicine and Sciences, King's College London , London ,","place":["UK"]},{"name":"Guy's and St Thomas\u2019 Hospital Department of Cardiology, , London ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric J","family":"Velazquez","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Section of Cardiovascular Medicine, Yale School of Medicine , New Haven, CT ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gavin J","family":"Murphy","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Sciences, University of Leicester , Leicester ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0050-5178","authenticated-orcid":false,"given":"Emanuele","family":"Barbato","sequence":"additional","affiliation":[{"name":"Department of Clinical and Molecular Medicine, Sapienza University , Rome ,","place":["Italy"]},{"name":"Cardiology Unit, Sant\u2019Andrea University Hospital , Rome ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4867-8588","authenticated-orcid":false,"given":"David J","family":"Maron","sequence":"additional","affiliation":[{"name":"Department of Medicine, Stanford University School of Medicine , Stanford, CA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Metra","sequence":"additional","affiliation":[{"name":"Cardiology, Vita-salute San Raffaele University and IRCCS San Raffaele Hospital, Milan ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5223-5782","authenticated-orcid":false,"given":"Stamatis","family":"Adamopoulos","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Onassis Cardiac Surgery Center Athens , Athens ,","place":["Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6333-9496","authenticated-orcid":false,"given":"Mark C","family":"Petrie","sequence":"additional","affiliation":[{"name":"School of Cardiovascular and Metabolic Health, University of Glasgow , Glasgow ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8364-3447","authenticated-orcid":false,"given":"Dimitrios","family":"Farmakis","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Attikon University Hospital, National and Kapodistrian University of Athens Medical School , Athens ,","place":["Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3044-197X","authenticated-orcid":false,"given":"Antoni","family":"Bayes-Genis","sequence":"additional","affiliation":[{"name":"Department of Medicine, Universitat Aut\u00f2noma de Barcelona , Barcelona ,","place":["Spain"]},{"name":"Institut del Cor, Hospital Universitari Germans Trias I Pujol , Barcelona ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2976-2514","authenticated-orcid":false,"given":"Michael","family":"B\u00f6hm","sequence":"additional","affiliation":[{"name":"Homburg Institute of CardioRenalMetabolic Medicine (HOMICAREM), Saarland University Klinik f\u00fcr Innere Medizin III and , Kirrberger Stra\u00dfe 100, 66421 Homburg\/Saar ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,7,24]]},"reference":[{"key":"2026081111263978600_xuag230-B1","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1161\/circulationaha.113.004046","article-title":"The global burden of ischemic heart disease in 1990 and 2010: the Global Burden of Disease 2010 study","volume":"129","author":"Moran","year":"2014","journal-title":"Circulation"},{"key":"2026081111263978600_xuag230-B2","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1161\/circulationaha.106.623199","article-title":"Navigating the crossroads of coronary artery disease and heart failure","volume":"114","author":"Gheorghiade","year":"2006","journal-title":"Circulation"},{"key":"2026081111263978600_xuag230-B3","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1161\/circulationaha.111.080770","article-title":"Trends in patients hospitalized with heart failure and preserved left ventricular ejection fraction: prevalence, therapies, and outcomes","volume":"126","author":"Steinberg","year":"2012","journal-title":"Circulation"},{"key":"2026081111263978600_xuag230-B4","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1253\/circj.CJ-18-0073","article-title":"Clinical characteristics, management, and outcomes of Japanese patients hospitalized for heart failure with preserved ejection fraction\u2014A report from the Japanese Heart Failure Syndrome With Preserved Ejection Fraction (JASPER) registry","volume":"82","author":"Nagai","year":"2018","journal-title":"Circ J"},{"key":"2026081111263978600_xuag230-B5","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/j.jacc.2007.04.064","article-title":"Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF registry","volume":"50","author":"Fonarow","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"2026081111263978600_xuag230-B6","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1016\/j.jacc.2021.07.004","article-title":"Myocardial viability assessment before surgical revascularization in ischemic cardiomyopathy: JACC review topic of the week","volume":"78","author":"Panza","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"2026081111263978600_xuag230-B7","doi-asserted-by":"publisher","first-page":"3070","DOI":"10.1161\/circulationaha.108.815944","article-title":"Relation of disease pathogenesis and risk factors to heart failure with preserved or reduced ejection fraction: insights from the framingham heart study of the national heart, lung, and blood institute","volume":"119","author":"Lee","year":"2009","journal-title":"Circulation"},{"key":"2026081111263978600_xuag230-B8","doi-asserted-by":"publisher","first-page":"3738","DOI":"10.1161\/circulationaha.105.561423","article-title":"Influence of ejection fraction on cardiovascular outcomes in a broad spectrum of heart failure patients","volume":"112","author":"Solomon","year":"2005","journal-title":"Circulation"},{"key":"2026081111263978600_xuag230-B9","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1093\/eurheartj\/ehy394","article-title":"2018 ESC\/EACTS Guidelines on myocardial revascularization","volume":"40","author":"Neumann","year":"2019","journal-title":"Eur Heart J"},{"key":"2026081111263978600_xuag230-B10","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/ejhf.2333","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). With the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"24","author":"McDonagh","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"2026081111263978600_xuag230-B11","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/ejhf.3024","article-title":"2023 focused update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) with the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"26","author":"McDonagh","year":"2024","journal-title":"Eur J Heart Fail"},{"key":"2026081111263978600_xuag230-B12","doi-asserted-by":"publisher","first-page":"3415","DOI":"10.1093\/eurheartj\/ehae177","article-title":"2024 ESC Guidelines for the management of chronic coronary syndromes","volume":"45","author":"Vrints","year":"2024","journal-title":"Eur Heart J"},{"key":"2026081111263978600_xuag230-B13","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1093\/eurjhf\/hfq230","article-title":"The Heart Failure Revascularisation Trial (HEART)","volume":"13","author":"Cleland","year":"2011","journal-title":"Eur J Heart Fail"},{"key":"2026081111263978600_xuag230-B14","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1056\/NEJMoa2206606","article-title":"Percutaneous revascularization for ischemic left ventricular dysfunction","volume":"387","author":"Perera","year":"2022","journal-title":"N Engl J Med"},{"key":"2026081111263978600_xuag230-B15","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1056\/NEJMoa1100356","article-title":"Coronary-artery bypass surgery in patients with left ventricular dysfunction","volume":"364","author":"Velazquez","year":"2011","journal-title":"N Engl J Med"},{"key":"2026081111263978600_xuag230-B16","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1056\/NEJMoa1602001","article-title":"Coronary-artery bypass surgery in patients with ischemic cardiomyopathy","volume":"374","author":"Velazquez","year":"2016","journal-title":"N Engl J Med"},{"key":"2026081111263978600_xuag230-B17","doi-asserted-by":"publisher","DOI":"10.1161\/circimaging.115.004331","article-title":"Long-term follow-up of outcomes with F-18-fluorodeoxyglucose positron emission tomography imaging-assisted management of patients with severe left ventricular dysfunction secondary to coronary disease","volume":"9","author":"Mc Ardle","year":"2016","journal-title":"Circ Cardiovasc Imaging"},{"key":"2026081111263978600_xuag230-B18","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1016\/j.jacc.2007.09.006","article-title":"F-18-fluorodeoxyglucose positron emission tomography imaging-assisted management of patients with severe left ventricular dysfunction and suspected coronary disease: a randomized, controlled trial (PARR-2)","volume":"50","author":"Beanlands","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"2026081111263978600_xuag230-B19","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1056\/NEJMoa1915922","article-title":"Initial invasive or conservative strategy for stable coronary disease","volume":"382","author":"Maron","year":"2020","journal-title":"N Engl J Med"},{"key":"2026081111263978600_xuag230-B20","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1056\/NEJMoa070829","article-title":"Optimal medical therapy with or without PCI for stable coronary disease","volume":"356","author":"Boden","year":"2007","journal-title":"N Engl J Med"},{"key":"2026081111263978600_xuag230-B21","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1002\/ejhf.2911","article-title":"Coronary revascularization for heart failure with coronary artery disease: a systematic review and meta-analysis of randomized trials","volume":"25","author":"Iaconelli","year":"2023","journal-title":"Eur J Heart Fail"},{"key":"2026081111263978600_xuag230-B22","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1002\/ehf2.12019","article-title":"Predictive power of late gadolinium enhancement for myocardial recovery in chronic ischaemic heart failure: a HEART sub-study","volume":"1","author":"McDiarmid","year":"2014","journal-title":"ESC Heart Fail"},{"key":"2026081111263978600_xuag230-B23","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1056\/NEJMoa1807365","article-title":"Myocardial viability and long-term outcomes in ischemic cardiomyopathy","volume":"381","author":"Panza","year":"2019","journal-title":"N Engl J Med"},{"key":"2026081111263978600_xuag230-B24","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1002\/ejhf.288","article-title":"Clinical characteristics and outcomes of patients with and without diabetes in the Surgical Treatment for Ischemic Heart Failure (STICH) trial","volume":"17","author":"MacDonald","year":"2015","journal-title":"Eur J Heart Fail"},{"key":"2026081111263978600_xuag230-B25","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1161\/circulationaha.116.024800","article-title":"Ten-year outcomes after coronary artery bypass grafting according to age in patients with heart failure and left ventricular systolic dysfunction: an analysis of the extended follow-up of the STICH trial (Surgical Treatment for Ischemic Heart Failure)","volume":"134","author":"Petrie","year":"2016","journal-title":"Circulation"},{"key":"2026081111263978600_xuag230-B26","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1016\/j.jchf.2024.03.010","article-title":"Effect of PCI on health status in ischemic left ventricular dysfunction: insights from REVIVED-BCIS2","volume":"12","author":"Ryan","year":"2024","journal-title":"JACC Heart Fail"},{"key":"2026081111263978600_xuag230-B27","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.jacc.2024.04.043","article-title":"Impact of anatomical and viability-guided completeness of revascularization on clinical outcomes in ischemic cardiomyopathy","volume":"84","author":"Ezad","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"2026081111263978600_xuag230-B28","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1093\/eurheartj\/ehaf080","article-title":"Medical therapy and outcomes in REVIVED-BCIS2 and STICHES: an individual patient data analysis","volume":"46","author":"Ryan","year":"2025","journal-title":"Eur Heart J"},{"key":"2026081111263978600_xuag230-B29","doi-asserted-by":"publisher","DOI":"10.1161\/jaha.122.026656","article-title":"Deferral of coronary revascularization in patients with reduced ejection fraction based on physiological assessment: impact on long-term survival","volume":"11","author":"Gallinoro","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"2026081111263978600_xuag230-B30","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1093\/eurheartj\/ehz571","article-title":"Fractional flow reserve in patients with reduced ejection fraction","volume":"41","author":"Di Gioia","year":"2020","journal-title":"Eur Heart J"},{"key":"2026081111263978600_xuag230-B31","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.jacc.2010.04.012","article-title":"Fractional flow reserve versus angiography for guiding percutaneous coronary intervention in patients with multivessel coronary artery disease: 2-year follow-up of the FAME (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation) study","volume":"56","author":"Pijls","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"2026081111263978600_xuag230-B32","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1056\/NEJMoa0807611","article-title":"Fractional flow reserve versus angiography for guiding percutaneous coronary intervention","volume":"360","author":"Tonino","year":"2009","journal-title":"N Engl J Med"},{"key":"2026081111263978600_xuag230-B33","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1016\/s0140-6736(15)00057-4","article-title":"Fractional flow reserve versus angiography for guidance of PCI in patients with multivessel coronary artery disease (FAME): 5-year follow-up of a randomised controlled trial","volume":"386","author":"van Nunen","year":"2015","journal-title":"Lancet"},{"key":"2026081111263978600_xuag230-B34","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1056\/NEJMoa1205361","article-title":"Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease","volume":"367","author":"De Bruyne","year":"2012","journal-title":"N Engl J Med"},{"key":"2026081111263978600_xuag230-B35","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.ahj.2015.06.024","article-title":"Rationale and design of the Fractional Flow Reserve versus Angiography for Multivessel Evaluation (FAME) 3 trial: a comparison of fractional flow reserve-guided percutaneous coronary intervention and coronary artery bypass graft surgery in patients with multivessel coronary artery disease","volume":"170","author":"Zimmermann","year":"2015","journal-title":"Am Heart J"},{"key":"2026081111263978600_xuag230-B36","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1056\/NEJMoa2112299","article-title":"Fractional flow reserve-guided PCI as compared with coronary bypass surgery","volume":"386","author":"Fearon","year":"2022","journal-title":"N Engl J Med"},{"key":"2026081111263978600_xuag230-B37","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1161\/circulationaha.123.065770","article-title":"Fractional flow reserve-guided PCI or coronary bypass surgery for 3-vessel coronary artery disease: 3-year follow-up of the FAME 3 trial","volume":"148","author":"Zimmermann","year":"2023","journal-title":"Circulation"},{"key":"2026081111263978600_xuag230-B38","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.ahj.2013.07.007","article-title":"Prognostic importance of coronary anatomy and left ventricular ejection fraction despite optimal therapy: assessment of residual risk in the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation Trial","volume":"166","author":"Mancini","year":"2013","journal-title":"Am Heart J"},{"key":"2026081111263978600_xuag230-B39","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1161\/circulationaha.120.050304","article-title":"Initial invasive versus conservative management of stable ischemic heart disease in patients with a history of heart failure or left ventricular dysfunction: insights from the ISCHEMIA trial","volume":"142","author":"Lopes","year":"2020","journal-title":"Circulation"},{"key":"2026081111263978600_xuag230-B40","doi-asserted-by":"publisher","DOI":"10.1161\/jaha.122.026943","article-title":"Myocardial revascularization in patients with ischemic cardiomyopathy: for whom and how","volume":"12","author":"Liga","year":"2023","journal-title":"J Am Heart Assoc"},{"key":"2026081111263978600_xuag230-B41","doi-asserted-by":"publisher","first-page":"2657","DOI":"10.1093\/eurheartj\/ehab273","article-title":"Long-term mortality in patients with ischaemic heart failure revascularized with coronary artery bypass grafting or percutaneous coronary intervention: insights from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR)","volume":"42","author":"V\u00f6lz","year":"2021","journal-title":"Eur Heart J"},{"key":"2026081111263978600_xuag230-B42","doi-asserted-by":"publisher","first-page":"e012527","DOI":"10.1161\/circinterventions.122.012527","article-title":"STICH3C: rationale and study protocol","volume":"16","author":"Fremes","year":"2023","journal-title":"Circ Cardiovasc Interv"},{"key":"2026081111263978600_xuag230-B43","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s13063-024-07935-y","article-title":"Pragmatic randomized controlled trials: strengthening the concept through a robust international collaborative network: PRIME-9-Pragmatic Research and Innovation through Multinational Experimentation","volume":"25","author":"Omerovic","year":"2024","journal-title":"Trials"},{"key":"2026081111263978600_xuag230-B44","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1002\/ejhf.2583","article-title":"Revascularization and heart failure with preserved ejection fraction\u2014time for randomized trials","volume":"24","author":"Ryan","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"2026081111263978600_xuag230-B45","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.amjcard.2015.05.020","article-title":"Comparison of 5-year outcomes after coronary artery bypass grafting in heart failure patients with versus without preserved left ventricular ejection fraction (from the CREDO-Kyoto CABG Registry Cohort-2)","volume":"116","author":"Marui","year":"2015","journal-title":"Am J Cardiol"},{"key":"2026081111263978600_xuag230-B46","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/0735-1097(91)90589-2","article-title":"Congestive heart failure symptoms in patients with preserved left ventricular systolic function: analysis of the CASS registry","volume":"18","author":"Judge","year":"1991","journal-title":"J Am Coll Cardiol"},{"key":"2026081111263978600_xuag230-B47","doi-asserted-by":"publisher","first-page":"2817","DOI":"10.1016\/j.jacc.2014.03.034","article-title":"Implications of coronary artery disease in heart failure with preserved ejection fraction","volume":"63","author":"Hwang","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2026081111263978600_xuag230-B48","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1002\/ejhf.2446","article-title":"Revascularization in ischaemic heart failure with preserved ejection fraction: a nationwide cohort study","volume":"24","author":"Deo","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"2026081111263978600_xuag230-B49","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1001\/jamacardio.2016.1465","article-title":"Survival after coronary artery bypass grafting in patients with preoperative heart failure and preserved vs reduced ejection fraction","volume":"1","author":"Dal\u00e9n","year":"2016","journal-title":"JAMA Cardiol"},{"key":"2026081111263978600_xuag230-B50","doi-asserted-by":"publisher","first-page":"4431","DOI":"10.1093\/eurheartj\/ehab653","article-title":"Untangling the pathophysiologic link between coronary microvascular dysfunction and heart failure with preserved ejection fraction","volume":"42","author":"Sinha","year":"2021","journal-title":"Eur Heart J"},{"key":"2026081111263978600_xuag230-B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacadv.2025.102345","article-title":"The role of coronary microvascular dysfunction in heart failure with preserved ejection fraction","volume":"4","author":"Tzoumas","year":"2025","journal-title":"JACC Adv"},{"key":"2026081111263978600_xuag230-B52","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1001\/jamacardio.2021.1825","article-title":"Prevalence of coronary artery disease and coronary microvascular dysfunction in patients with heart failure with preserved ejection fraction","volume":"6","author":"Rush","year":"2021","journal-title":"JAMA Cardiol"},{"key":"2026081111263978600_xuag230-B53","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1002\/ejhf.2431","article-title":"Regional differences in precipitating factors of hospitalization for acute heart failure: insights from the REPORT-HF registry","volume":"24","author":"Tromp","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"2026081111263978600_xuag230-B54","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1002\/ejhf.245","article-title":"Clinical characteristics, management, and outcomes of acute heart failure patients: observations from the Gulf acute heart failure registry (Gulf CARE)","volume":"17","author":"Sulaiman","year":"2015","journal-title":"Eur J Heart Fail"},{"key":"2026081111263978600_xuag230-B55","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1253\/circj.CJ-20-0947","article-title":"Clinical characteristics and outcomes of hospitalized patients with heart failure from the large-scale Japanese Registry of Acute Decompensated Heart Failure (JROADHF)","volume":"85","author":"Ide","year":"2021","journal-title":"Circ J"},{"key":"2026081111263978600_xuag230-B56","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1002\/ejhf.566","article-title":"European Society of Cardiology Heart Failure Long-Term Registry (ESC-HF-LT): 1-year follow-up outcomes and differences across regions","volume":"18","author":"Crespo-Leiro","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"2026081111263978600_xuag230-B57","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1161\/01.Cir.0000109691.16944.Da","article-title":"Determinants and prognostic impact of heart failure complicating acute coronary syndromes: observations from the Global Registry of Acute Coronary Events (GRACE)","volume":"109","author":"Steg","year":"2004","journal-title":"Circulation"},{"key":"2026081111263978600_xuag230-B58","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.jchf.2013.02.007","article-title":"Heart failure complicating non-ST-segment elevation acute coronary syndrome: timing, predictors, and clinical outcomes","volume":"1","author":"Bahit","year":"2013","journal-title":"JACC Heart Fail"},{"key":"2026081111263978600_xuag230-B59","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/s0140-6736(02)09894-x","article-title":"Interventional versus conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction: the British Heart Foundation RITA 3 randomised trial. Randomized Intervention Trial of unstable Angina","volume":"360","author":"Fox","year":"2002","journal-title":"Lancet"},{"key":"2026081111263978600_xuag230-B60","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1056\/NEJMoa044259","article-title":"Early invasive versus selectively invasive management for acute coronary syndromes","volume":"353","author":"de Winter","year":"2005","journal-title":"N Engl J Med"},{"key":"2026081111263978600_xuag230-B61","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1056\/nejm200106213442501","article-title":"Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb\/IIIa inhibitor tirofiban","volume":"344","author":"Cannon","year":"2001","journal-title":"N Engl J Med"},{"key":"2026081111263978600_xuag230-B62","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1056\/NEJMoa055443","article-title":"Comparison of fondaparinux and enoxaparin in acute coronary syndromes","volume":"354","author":"Fifth Organization to Assess Strategies in Acute Ischemic Syndromes Investigators","year":"2006","journal-title":"N Engl J Med"},{"key":"2026081111263978600_xuag230-B63","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/S0140-6736(99)07349-3","article-title":"Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study. FRagmin and fast revascularisation during InStability in coronary artery disease investigators","volume":"354","year":"1999","journal-title":"Lancet"},{"key":"2026081111263978600_xuag230-B64","doi-asserted-by":"publisher","first-page":"e618","DOI":"10.1161\/cir.0000000000000617","article-title":"Fourth universal definition of myocardial infarction (2018)","volume":"138","author":"Thygesen","year":"2018","journal-title":"Circulation"},{"key":"2026081111263978600_xuag230-B65","doi-asserted-by":"publisher","first-page":"3720","DOI":"10.1093\/eurheartj\/ehad191","article-title":"2023 ESC guidelines for the management of acute coronary syndromes","volume":"44","author":"Byrne","year":"2023","journal-title":"Eur Heart J"},{"key":"2026081111263978600_xuag230-B66","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41572-020-0151-7","article-title":"Acute heart failure","volume":"6","author":"Arrigo","year":"2020","journal-title":"Nat Rev Dis Primers"},{"key":"2026081111263978600_xuag230-B67","doi-asserted-by":"publisher","first-page":"2174","DOI":"10.1001\/jama.290.16.2174","article-title":"Prognostic importance of physical examination for heart failure in non-ST-elevation acute coronary syndromes: the enduring value of Killip classification","volume":"290","author":"Khot","year":"2003","journal-title":"JAMA"},{"key":"2026081111263978600_xuag230-B68","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3109\/17482941.2011.567284","article-title":"Outcomes of acute heart failure associated with acute coronary syndrome versus other causes","volume":"13","author":"Greenberg","year":"2011","journal-title":"Acute Card Care"},{"key":"2026081111263978600_xuag230-B69","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s12872-016-0267-6","article-title":"Acute heart failure with and without acute coronary syndrome: clinical correlates and prognostic impact (from the HEARTS registry)","volume":"16","author":"AlFaleh","year":"2016","journal-title":"BMC Cardiovasc Disord"},{"key":"2026081111263978600_xuag230-B70","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1016\/s0735-1097(02)01726-6","article-title":"Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis","volume":"39","author":"Allman","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"2026081111263978600_xuag230-B71","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/s0140-6736(16)30677-8","article-title":"Acute myocardial infarction","volume":"389","author":"Reed","year":"2017","journal-title":"Lancet"},{"key":"2026081111263978600_xuag230-B72","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1016\/s0735-1097(02)02173-3","article-title":"Hospital outcomes in patients presenting with congestive heart failure complicating acute myocardial infarction: a report from the Second National Registry of Myocardial Infarction (NRMI-2)","volume":"40","author":"Wu","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"2026081111263978600_xuag230-B73","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1002\/clc.22745","article-title":"Heart failure in patients admitted for acute coronary syndromes: a report from a large national registry","volume":"40","author":"Jeger","year":"2017","journal-title":"Clin Cardiol"},{"key":"2026081111263978600_xuag230-B74","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1093\/eurjhf\/hfp151","article-title":"Heart failure in patients hospitalized with acute coronary syndromes: observations from the Gulf Registry of Acute Coronary Events (Gulf RACE)","volume":"11","author":"Alsheikh-Ali","year":"2009","journal-title":"Eur J Heart Fail"},{"key":"2026081111263978600_xuag230-B75","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1097\/MCA.0b013e328364d98f","article-title":"Prevalence and prognosis of congestive heart failure in Saudi patients admitted with acute coronary syndrome (from SPACE registry)","volume":"24","author":"Albackr","year":"2013","journal-title":"Coron Artery Dis"},{"key":"2026081111263978600_xuag230-B76","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.amjcard.2006.03.023","article-title":"Prognostic significance of admission heart failure in patients with non-ST-elevation acute coronary syndromes (from the Canadian Acute Coronary Syndrome Registries)","volume":"98","author":"Segev","year":"2006","journal-title":"Am J Cardiol"},{"key":"2026081111263978600_xuag230-B77","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/j.hlc.2015.10.007","article-title":"Management and long-term outcome of acute coronary syndrome patients presenting with heart failure in a contemporary New Zealand cohort (ANZACS-QI 4)","volume":"25","author":"Kueh","year":"2016","journal-title":"Heart Lung Circ"},{"key":"2026081111263978600_xuag230-B78","doi-asserted-by":"publisher","first-page":"2432","DOI":"10.1016\/j.jacc.2021.03.310","article-title":"Impact of percutaneous coronary intervention on outcomes in patients with heart failure: JACC state-of-the-art review","volume":"77","author":"Parikh","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"2026081111263978600_xuag230-B79","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1056\/nejm199908263410901","article-title":"Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK investigators. Should we emergently revascularize occluded coronaries for cardiogenic shock","volume":"341","author":"Hochman","year":"1999","journal-title":"N Engl J Med"},{"key":"2026081111263978600_xuag230-B80","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1056\/nejm199806183382501","article-title":"Outcomes in patients with acute non-Q-wave myocardial infarction randomly assigned to an invasive as compared with a conservative management strategy. Veterans Affairs Non-Q-Wave Infarction Strategies in Hospital (VANQWISH) Trial Investigators","volume":"338","author":"Boden","year":"1998","journal-title":"N Engl J Med"},{"key":"2026081111263978600_xuag230-B81","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1161\/01.cir.89.4.1545","article-title":"Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction. Results of the TIMI IIIB trial. Thrombolysis in Myocardial Ischemia","volume":"89","year":"1994","journal-title":"Circulation"},{"key":"2026081111263978600_xuag230-B82","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.ijcard.2017.01.153","article-title":"The prevalence of frailty in heart failure: a systematic review and meta-analysis","volume":"236","author":"Denfeld","year":"2017","journal-title":"Int J Cardiol"},{"key":"2026081111263978600_xuag230-B83","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1056\/NEJMoa2407791","article-title":"Invasive treatment strategy for older patients with myocardial infarction","volume":"391","author":"Kunadian","year":"2024","journal-title":"N Engl J Med"},{"key":"2026081111263978600_xuag230-B84","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.ejim.2021.08.003","article-title":"State of the art approach to managing angina and ischemia: tailoring treatment to the evidence","volume":"92","author":"Manolis","year":"2021","journal-title":"Eur J Intern Med"},{"key":"2026081111263978600_xuag230-B85","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1038\/s41569-021-00573-w","article-title":"A pathophysiological compass to personalize antianginal drug treatment","volume":"18","author":"Bertero","year":"2021","journal-title":"Nat Rev Cardiol"},{"key":"2026081111263978600_xuag230-B86","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1093\/eurheartj\/ehz425","article-title":"2019 ESC guidelines for the diagnosis and management of chronic coronary syndromes","volume":"41","author":"Knuuti","year":"2020","journal-title":"Eur Heart J"},{"key":"2026081111263978600_xuag230-B87","doi-asserted-by":"publisher","first-page":"e44","DOI":"10.1016\/j.jacc.2012.07.013","article-title":"2012 ACCF\/AHA\/ACP\/AATS\/PCNA\/SCAI\/STS Guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons","volume":"60","author":"Fihn","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"2026081111263978600_xuag230-B88","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1016\/s0140-6736(08)61240-4","article-title":"Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial","volume":"372","author":"Tavazzi","year":"2008","journal-title":"Lancet"},{"key":"2026081111263978600_xuag230-B89","doi-asserted-by":"publisher","first-page":"2248","DOI":"10.1056\/NEJMoa0706201","article-title":"Rosuvastatin in older patients with systolic heart failure","volume":"357","author":"Kjekshus","year":"2007","journal-title":"N Engl J Med"},{"key":"2026081111263978600_xuag230-B90","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1002\/ejhf.247","article-title":"Do statins reduce the risk of myocardial infarction in patients with heart failure? A pooled individual-level reanalysis of CORONA and GISSI-HF","volume":"17","author":"Feinstein","year":"2015","journal-title":"Eur J Heart Fail"},{"key":"2026081111263978600_xuag230-B91","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0171168","article-title":"No benefits of statins for sudden cardiac death prevention in patients with heart failure and reduced ejection fraction: a meta-analysis of randomized controlled trials","volume":"12","author":"Al-Gobari","year":"2017","journal-title":"PLoS One"},{"key":"2026081111263978600_xuag230-B92","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin-neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N Engl J Med"},{"key":"2026081111263978600_xuag230-B93","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1056\/NEJMoa2022190","article-title":"Cardiovascular and renal outcomes with empagliflozin in heart failure","volume":"383","author":"Packer","year":"2020","journal-title":"N Engl J Med"},{"key":"2026081111263978600_xuag230-B94","doi-asserted-by":"publisher","first-page":"3627","DOI":"10.1093\/eurheartj\/ehad195","article-title":"2023 focused update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"44","author":"McDonagh","year":"2023","journal-title":"Eur Heart J"},{"key":"2026081111263978600_xuag230-B95","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1056\/NEJMoa0906431","article-title":"Cardiac-resynchronization therapy for the prevention of heart-failure events","volume":"361","author":"Moss","year":"2009","journal-title":"N Engl J Med"},{"key":"2026081111263978600_xuag230-B96","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.1056\/NEJMoa1009540","article-title":"Cardiac-resynchronization therapy for mild-to-moderate heart failure","volume":"363","author":"Tang","year":"2010","journal-title":"N Engl J Med"},{"key":"2026081111263978600_xuag230-B97","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1056\/NEJMoa2300213","article-title":"Five-year follow-up after transcatheter repair of secondary mitral regurgitation","volume":"388","author":"Stone","year":"2023","journal-title":"N Engl J Med"},{"key":"2026081111263978600_xuag230-B98","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1056\/NEJMoa1806640","article-title":"Transcatheter mitral-valve repair in patients with heart failure","volume":"379","author":"Stone","year":"2018","journal-title":"N Engl J Med"},{"key":"2026081111263978600_xuag230-B99","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1056\/NEJMoa2314328","article-title":"Transcatheter valve repair in heart failure with moderate to severe mitral regurgitation","volume":"391","author":"Anker","year":"2024","journal-title":"N Engl J Med"},{"key":"2026081111263978600_xuag230-B100","doi-asserted-by":"publisher","first-page":"e009960","DOI":"10.1161\/circheartfailure.122.009960","article-title":"Use of a pulmonary artery pressure sensor to manage patients with left ventricular assist devices","volume":"16","author":"Thohan","year":"2023","journal-title":"Circ Heart Fail"},{"key":"2026081111263978600_xuag230-B101","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1056\/NEJMoa2306037","article-title":"Catheter ablation in end-stage heart failure with atrial fibrillation","volume":"389","author":"Sohns","year":"2023","journal-title":"N Engl J Med"},{"key":"2026081111263978600_xuag230-B102","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1001\/jama.2022.16197","article-title":"Five-year outcomes in patients with fully magnetically levitated vs axial-flow left ventricular assist devices in the MOMENTUM 3 randomized trial","volume":"328","author":"Mehra","year":"2022","journal-title":"JAMA"},{"key":"2026081111263978600_xuag230-B103","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1016\/s0140-6736(23)00923-6","article-title":"Remote haemodynamic monitoring of pulmonary artery pressures in patients with chronic heart failure (MONITOR-HF): a randomised clinical trial","volume":"401","author":"Brugts","year":"2023","journal-title":"Lancet"},{"key":"2026081111263978600_xuag230-B104","doi-asserted-by":"publisher","DOI":"10.1161\/circheartfailure.115.002600","article-title":"Pulmonary artery pressure-guided heart failure management reduces 30-day readmissions","volume":"9","author":"Adamson","year":"2016","journal-title":"Circ Heart Fail"},{"key":"2026081111263978600_xuag230-B105","doi-asserted-by":"publisher","first-page":"2674","DOI":"10.1016\/j.jacc.2024.03.431","article-title":"Intravenous iron repletion for patients with heart failure and iron deficiency: JACC state-of-the-art review","volume":"83","author":"Cheema","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"2026081111263978600_xuag230-B106","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1001\/jama.2009.454","article-title":"Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial","volume":"301","author":"O'Connor","year":"2009","journal-title":"JAMA"},{"key":"2026081111263978600_xuag230-B107","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1001\/jama.2015.17346","article-title":"Effect of caloric restriction or aerobic exercise training on peak oxygen consumption and quality of life in obese older patients with heart failure with preserved ejection fraction: a randomized clinical trial","volume":"315","author":"Kitzman","year":"2016","journal-title":"JAMA"},{"key":"2026081111263978600_xuag230-B108","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1056\/NEJMoa2410027","article-title":"Tirzepatide for heart failure with preserved ejection fraction and obesity","volume":"392","author":"Packer","year":"2025","journal-title":"N Engl J Med"},{"key":"2026081111263978600_xuag230-B109","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1056\/NEJMoa2306963","article-title":"Semaglutide in patients with heart failure with preserved ejection fraction and obesity","volume":"389","author":"Kosiborod","year":"2023","journal-title":"N Engl J Med"},{"key":"2026081111263978600_xuag230-B110","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1093\/eurheartj\/ehw140","article-title":"Taxonomy of segmental myocardial systolic dysfunction","volume":"38","author":"McDiarmid","year":"2017","journal-title":"Eur Heart J"},{"key":"2026081111263978600_xuag230-B111","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1093\/eurheartj\/ehae844","article-title":"Prognostic impact of inducible ischaemia in ischaemic left ventricular dysfunction: the REVIVED-BCIS2 trial","volume":"46","author":"Morgan","year":"2025","journal-title":"Eur Heart J"},{"key":"2026081111263978600_xuag230-B112","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1001\/jamacardio.2023.3803","article-title":"Viability and outcomes with revascularization or medical therapy in ischemic ventricular dysfunction: a prespecified secondary analysis of the REVIVED-BCIS2 trial","volume":"8","author":"Perera","year":"2023","journal-title":"JAMA Cardiol"},{"key":"2026081111263978600_xuag230-B113","doi-asserted-by":"publisher","DOI":"10.1161\/circheartfailure.118.005531","article-title":"Society of thoracic surgeons risk score and EuroSCORE-2 appropriately assess 30-day postoperative mortality in the STICH trial and a contemporary cohort of patients with left ventricular dysfunction undergoing surgical revascularization","volume":"11","author":"Bouabdallaoui","year":"2018","journal-title":"Circ Heart Fail"},{"key":"2026081111263978600_xuag230-B114","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/s0140-6736(13)60108-7","article-title":"Anatomical and clinical characteristics to guide decision making between coronary artery bypass surgery and percutaneous coronary intervention for individual patients: development and validation of SYNTAX score II","volume":"381","author":"Farooq","year":"2013","journal-title":"Lancet"},{"key":"2026081111263978600_xuag230-B115","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1093\/eurheartj\/ehab680","article-title":"Myocardial revascularization in ischaemic cardiomyopathy: routine practice vs. scientific evidence","volume":"43","author":"De Caterina","year":"2022","journal-title":"Eur Heart J"},{"key":"2026081111263978600_xuag230-B116","doi-asserted-by":"publisher","first-page":"3652","DOI":"10.1093\/eurheartj\/ehad488","article-title":"REVIV(E)ing the ischaemic paradigm in heart failure: STICHes are needed","volume":"44","author":"Rohde","year":"2023","journal-title":"Eur Heart J"},{"key":"2026081111263978600_xuag230-B117","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1161\/circulationaha.120.050734","article-title":"Association of inducible myocardial ischemia with long-term mortality and benefit from coronary artery bypass graft surgery in ischemic cardiomyopathy: ten-year follow-up of the STICH trial","volume":"143","author":"O'Fee","year":"2021","journal-title":"Circulation"},{"key":"2026081111263978600_xuag230-B118","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1016\/j.jacc.2013.02.014","article-title":"Inducible myocardial ischemia and outcomes in patients with coronary artery disease and left ventricular dysfunction","volume":"61","author":"Panza","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2026081111263978600_xuag230-B119","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.jcmg.2009.02.017","article-title":"Increasing benefit from revascularization is associated with increasing amounts of myocardial hibernation: a substudy of the PARR-2 trial","volume":"2","author":"D'Egidio","year":"2009","journal-title":"JACC Cardiovasc Imaging"}],"container-title":["European Journal of Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurjhf\/advance-article-pdf\/doi\/10.1093\/ejhf\/xuag230\/69939922\/xuag230.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurjhf\/advance-article-pdf\/doi\/10.1093\/ejhf\/xuag230\/69939922\/xuag230.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T15:44:49Z","timestamp":1786463089000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurjhf\/advance-article\/doi\/10.1093\/ejhf\/xuag230\/8741289"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,24]]},"references-count":119,"URL":"https:\/\/doi.org\/10.1093\/ejhf\/xuag230","relation":{},"ISSN":["1388-9842","1879-0844"],"issn-type":[{"value":"1388-9842","type":"print"},{"value":"1879-0844","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,24]]},"article-number":"xuag230"}}